Patents by Inventor Fiona Roberts

Fiona Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIMICROBIAL COMPOUNDS
    Publication number: 20110245324
    Abstract: The present invention relates to compounds that modulate the shikimate pathway and/or a pathway branching from the shikimate pathway in members of the Amoebida Order. In particular these compounds may be useful in the treatment or prevention of diseases caused or contributed to by members of the Amoebida Order.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 6, 2011
    Applicant: University of Strathclyde
    Inventors: Craig William Roberts, Fiona Roberts, Fiona Luisa Henriquez, Paul Richard Ingram
  • Antimicrobial compounds
    Patent number: 7972610
    Abstract: The present invention relates to compounds that modulate the shikimate pathway and/or a pathway branching from the shikimate pathway in members of the Amoebida Order. In particular these compounds may be useful in the treatment or prevention of diseases caused or contributed to by members of the Amoebida Order.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: July 5, 2011
    Assignee: University of Strathclyde
    Inventors: Craig William Roberts, Fiona Roberts, Fiona Luisa Henriquez, Paul Richard Ingram
  • Antimicrobial Compounds
    Publication number: 20080249051
    Abstract: The present invention relates to compounds that modulate the shikimate pathway and/or a pathway branching from the shikimate pathway in members of the Amoebida Order. In particular these compounds may be useful in the treatment or prevention of diseases caused or contributed to by members of the Amoebida Order.
    Type: Application
    Filed: March 13, 2006
    Publication date: October 9, 2008
    Applicant: University of Strathclyde
    Inventors: Craig William Roberts, Fiona Roberts, Fiona Luisa Henriquez, Paul Richard Ingram
  • Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
    Publication number: 20050142113
    Abstract: This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
    Type: Application
    Filed: April 14, 2004
    Publication date: June 30, 2005
    Inventors: Rima McLeod, Craig Roberts, Fiona Roberts, Jennifer Johnson, Michael Kirisits, David Ferguson, Russell Lyons, Ernest Mui, Doug Mack, Benjamin Samuel, Piotr Gornicki, Ellen Zuther
  • Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components
    Patent number: 6737237
    Abstract: This invention relates uses of Toxoplasma gondii chorismate synthase, a component components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, in assays to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on T. gondii chorismate synthase and its inhibitors.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: May 18, 2004
    Assignee: Apicomplexan Therapeutics, LLC
    Inventors: Rima L. McLeod, Craig W. Roberts, Fiona Roberts, Jennifer J. Johnson, Michael Kirisits, David Ferguson, Russell Lyons, Ernest Mui, Doug Mack, Benjamin Samuel, Piotr Gornicki, Ellen Zuther
  • Antimicrobial agents diagnostic reagents, and vaccines based on unique apicomplexan parasite components
    Patent number: 6699654
    Abstract: This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: March 2, 2004
    Inventors: Rima L. W. McLeod, Craig W. Roberts, Fiona Roberts, Jennifer J. Johnson, Laurens Mets